How severe is CVE-2017-11566?

CVE-2017-11566 has a CVSS 3.x base score of 7.8, rated high severity. It is exploitable over local access with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2017-11566 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (53rd percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2017-11566?

CVE-2017-11566 affects Appsec-labs Appuse. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2017-11566?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

When was CVE-2017-11566 published?

CVE-2017-11566 was published on 2017-07-25 and last updated on 2026-06-17.

CVE-2017-11566

CVE-2017-11566 is a high-severity vulnerability in Appsec-labs Appuse with a CVSS 3.x base score of 7.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-78.

Key facts

Severity: High (CVSS 3.x base score 7.8)
CVSS v2: 7.2
EPSS exploit prediction: 1% (53rd percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-78
Affected product: Appsec-labs Appuse
Published: 2017-07-25
Last modified: 2026-06-17

Description

AppUse 4.0 allows shell command injection via a proxy field.

Frequently asked questions

What is CVE-2017-11566?: AppUse 4.0 allows shell command injection via a proxy field.
How severe is CVE-2017-11566?: CVE-2017-11566 has a CVSS 3.x base score of 7.8, rated high severity. It is exploitable over local access with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2017-11566 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (53rd percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2017-11566?: CVE-2017-11566 affects Appsec-labs Appuse. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2017-11566?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2017-11566 published?: CVE-2017-11566 was published on 2017-07-25 and last updated on 2026-06-17.

References

https://gist.github.com/shiham101/4807e3dea54ee0f0456c47fcd1400e97

Affected products (1)

cpe:2.3:a:appsec-labs:appuse:4.0:*:*:*:*:*:*:*

Other CWE-78 (OS Command Injection) vulnerabilities

CVE-2026-56004 — Critical (CVSS 10.0): A shellcode injection in the mercurial handler of the obs tar_scm source service before version 0.12.4 could be used by…
CVE-2026-56415 — Critical (CVSS 10.0): Storage Concentrator (SC & SCVM) contains a command injection vulnerability within the debug.pl script that is…
CVE-2026-56413 — Critical (CVSS 10.0): Storage Concentrator (SC & SCVM) contains a command injection vulnerability in the ms_service.pl service, which listens…
CVE-2026-49869 — Critical (CVSS 10.0): Kestra is an open-source, event-driven orchestration platform. Prior to 1.0.45 and 1.3.21, AuthenticationFilter in…
CVE-2026-49261 — Critical (CVSS 10.0): MariaDB server is a community developed fork of MySQL server. Versions 10.6.1 through 10.6.26, 10.11.1 through…
CVE-2026-10520 — Critical (CVSS 10.0): An OS Command Injection vulnerability in Ivanti Sentry before the R10.5.2, R10.6.2 and R10.7.1 versions allows a…

Browse all CWE-78 (OS Command Injection) vulnerabilities →